Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Haider

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Breast Cancer Research and Treatment|December 8, 2000
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factorW Kwasny, G Kornek, K Haider, et al.
Journal of Medical Microbiology|November 1, 1992
Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alveiM J Albert, S M Faruque, M Ansaruzzaman, et al.
Investigational New Drugs|May 1, 1990
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II studyW Scheithauer, H Samonigg, D Depisch, et al.
Cancer|April 3, 2001
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trialW Scheithauer, G V Kornek, H Ulrich-Pur, et al.
Journal of Clinical Microbiology|September 1, 1991
Outbreak of keratoconjunctivitis due to Salmonella weltevreden in a guinea pig colonyM J Albert, M Ansaruzzaman, S M Faruque, et al.
Infection and Immunity|May 1, 1991
Localized adherence and attaching-effacing properties of nonenteropathogenic serotypes of Escherichia coliM J Albert, K Alam, M Ansaruzzaman, et al.
Journal of Clinical Microbiology|May 1, 1992
Characterization of Aeromonas caviae antigens which cross-react with Shigella boydii 5M J Albert, F Qadri, M Ansaruzzaman, et al.
Journal of Diarrhoeal Diseases Research|December 1, 1991
Enteroaggregative Escherichia coli infections in Bangladeshi children: clinical and microbiological featuresK Haider, S M Faruque, N S Shahid, et al.
Journal of Clinical Microbiology|November 1, 1992
Differentiation of Shigella flexneri strains by rRNA gene restriction patternsS M Faruque, K Haider, M M Rahman, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Breast Cancer Research and Treatment|December 8, 2000
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factorW Kwasny, G Kornek, K Haider, et al.
Journal of Medical Microbiology|November 1, 1992
Sharing of virulence-associated properties at the phenotypic and genetic levels between enteropathogenic Escherichia coli and Hafnia alveiM J Albert, S M Faruque, M Ansaruzzaman, et al.
Investigational New Drugs|May 1, 1990
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II studyW Scheithauer, H Samonigg, D Depisch, et al.
Cancer|April 3, 2001
Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trialW Scheithauer, G V Kornek, H Ulrich-Pur, et al.
Journal of Clinical Microbiology|September 1, 1991
Outbreak of keratoconjunctivitis due to Salmonella weltevreden in a guinea pig colonyM J Albert, M Ansaruzzaman, S M Faruque, et al.
Infection and Immunity|May 1, 1991
Localized adherence and attaching-effacing properties of nonenteropathogenic serotypes of Escherichia coliM J Albert, K Alam, M Ansaruzzaman, et al.
Journal of Clinical Microbiology|May 1, 1992
Characterization of Aeromonas caviae antigens which cross-react with Shigella boydii 5M J Albert, F Qadri, M Ansaruzzaman, et al.
Journal of Diarrhoeal Diseases Research|December 1, 1991
Enteroaggregative Escherichia coli infections in Bangladeshi children: clinical and microbiological featuresK Haider, S M Faruque, N S Shahid, et al.
Journal of Clinical Microbiology|November 1, 1992
Differentiation of Shigella flexneri strains by rRNA gene restriction patternsS M Faruque, K Haider, M M Rahman, et al.
Pageof 9